Iron-dependent Self-assembly of Recombinant Yeast Frataxin: Implications for Friedreich Ataxia

Overview

Journal Am J Hum Genet

Publisher Cell Press

Specialty Genetics

Date 2000 Aug 10

PMID 10930361

Citations 82

Authors

J Adamec

F Rusnak

W G Owen

S Naylor

L M Benson

A M Gacy

G Isaya

Affiliations

Soon will be listed here.

Abstract

Frataxin deficiency is the primary cause of Friedreich ataxia (FRDA), an autosomal recessive cardiodegenerative and neurodegenerative disease. Frataxin is a nuclear-encoded mitochondrial protein that is widely conserved among eukaryotes. Genetic inactivation of the yeast frataxin homologue (Yfh1p) results in mitochondrial iron accumulation and hypersensitivity to oxidative stress. Increased iron deposition and evidence of oxidative damage have also been observed in cardiac tissue and cultured fibroblasts from patients with FRDA. These findings indicate that frataxin is essential for mitochondrial iron homeostasis and protection from iron-induced formation of free radicals. The functional mechanism of frataxin, however, is still unknown. We have expressed the mature form of Yfh1p (mYfh1p) in Escherichia coli and have analyzed its function in vitro. Isolated mYfh1p is a soluble monomer (13,783 Da) that contains no iron and shows no significant tendency to self-associate. Aerobic addition of ferrous iron to mYfh1p results in assembly of regular spherical multimers with a molecular mass of approximately 1. 1 MDa (megadaltons) and a diameter of 13+/-2 nm. Each multimer consists of approximately 60 subunits and can sequester >3,000 atoms of iron. Titration of mYfh1p with increasing iron concentrations supports a stepwise mechanism of multimer assembly. Sequential addition of an iron chelator and a reducing agent results in quantitative iron release with concomitant disassembly of the multimer, indicating that mYfh1p sequesters iron in an available form. In yeast mitochondria, native mYfh1p exists as monomer and a higher-order species with a molecular weight >600,000. After addition of (55)Fe to the medium, immunoprecipitates of this species contain >16 atoms of (55)Fe per molecule of mYfh1p. We propose that iron-dependent self-assembly of recombinant mYfh1p reflects a physiological role for frataxin in mitochondrial iron sequestration and bioavailability.

Citing Articles

A global perspective on research advances and future challenges in Friedreich ataxia.

Indelicato E, Delatycki M, Farmer J, Franca Jr M, Perlman S, Rai M Nat Rev Neurol. 2025; .

PMID: 40032987 DOI: 10.1038/s41582-025-01065-y.

CyaY and TusA regulate ISC- and SUF-mediated l-cysteine desulfurase activity.

Olivieri P, Crack J, Lehmann A, Le Brun N, Leimkuhler S RSC Chem Biol. 2024; .

PMID: 39372677 PMC: 11446229. DOI: 10.1039/d4cb00225c.

Apparent Opportunities and Hidden Pitfalls: The Conflicting Results of Restoring NRF2-Regulated Redox Metabolism in Friedreich's Ataxia Pre-Clinical Models and Clinical Trials.

Tiberi J, Segatto M, Fiorenza M, La Rosa P Biomedicines. 2023; 11(5).

PMID: 37238963 PMC: 10215444. DOI: 10.3390/biomedicines11051293.

Frataxin deficiency alters gene expression in Friedreich ataxia derived IPSC-neurons and cardiomyocytes.

Angulo M, Bertalovitz A, Argenziano M, Yang J, Patel A, Zesiewicz T Mol Genet Genomic Med. 2022; 11(1):e2093.

PMID: 36369844 PMC: 9834160. DOI: 10.1002/mgg3.2093.

Structural and Functional Characterization of CreFH1, the Frataxin Homolog from .

Terenzi A, Pagani M, Gomez-Casati D, Busi M Plants (Basel). 2022; 11(15).

PMID: 35893635 PMC: 9331050. DOI: 10.3390/plants11151931.

References

Nixon D, Moyer T, Johnson P, McCALL J, Ness A, Fjerstad W . Routine measurement of calcium, magnesium, copper, zinc, and iron in urine and serum by inductively coupled plasma emission spectroscopy. Clin Chem. 1986; 32(9):1660-5. View

Matsudaira P . Sequence from picomole quantities of proteins electroblotted onto polyvinylidene difluoride membranes. J Biol Chem. 1987; 262(21):10035-8. View

Gavel Y, von Heijne G . Cleavage-site motifs in mitochondrial targeting peptides. Protein Eng. 1990; 4(1):33-7. DOI: 10.1093/protein/4.1.33. View

Tangeras A . Mitochondrial iron not bound in heme and iron-sulfur centers and its availability for heme synthesis in vitro. Biochim Biophys Acta. 1985; 843(3):199-207. DOI: 10.1016/0304-4165(85)90140-0. View

Harrison P, Arosio P . The ferritins: molecular properties, iron storage function and cellular regulation. Biochim Biophys Acta. 1996; 1275(3):161-203. DOI: 10.1016/0005-2728(96)00022-9. View

Campuzano V, Montermini L, Molto M, Pianese L, Cossee M, Cavalcanti F . Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion. Science. 1996; 271(5254):1423-7. DOI: 10.1126/science.271.5254.1423. View

Richards T, Pitts K, Watt G . A kinetic study of iron release from Azotobacter vinelandii bacterial ferritin. J Inorg Biochem. 1996; 61(1):1-13. DOI: 10.1016/0162-0134(95)00029-1. View

Koutnikova H, Campuzano V, Koenig M . Maturation of wild-type and mutated frataxin by the mitochondrial processing peptidase. Hum Mol Genet. 1998; 7(9):1485-9. DOI: 10.1093/hmg/7.9.1485. View

Bradley J, BLAKE J, Chamberlain S, Thomas P, Cooper J, Schapira A . Clinical, biochemical and molecular genetic correlations in Friedreich's ataxia. Hum Mol Genet. 1999; 9(2):275-82. DOI: 10.1093/hmg/9.2.275. View

10.

Rotig A, de Lonlay P, Chretien D, Foury F, Koenig M, Sidi D . Aconitase and mitochondrial iron-sulphur protein deficiency in Friedreich ataxia. Nat Genet. 1997; 17(2):215-7. DOI: 10.1038/ng1097-215. View

11.

Chen O, Kaplan J . CCC1 suppresses mitochondrial damage in the yeast model of Friedreich's ataxia by limiting mitochondrial iron accumulation. J Biol Chem. 2000; 275(11):7626-32. DOI: 10.1074/jbc.275.11.7626. View

12.

DE SILVA D, Askwith C, Kaplan J . Molecular mechanisms of iron uptake in eukaryotes. Physiol Rev. 1996; 76(1):31-47. DOI: 10.1152/physrev.1996.76.1.31. View

13.

Hansma H, Hoh J . Biomolecular imaging with the atomic force microscope. Annu Rev Biophys Biomol Struct. 1994; 23:115-39. DOI: 10.1146/annurev.bb.23.060194.000555. View

14.

Campuzano V, Montermini L, Lutz Y, Cova L, Hindelang C, Jiralerspong S . Frataxin is reduced in Friedreich ataxia patients and is associated with mitochondrial membranes. Hum Mol Genet. 1997; 6(11):1771-80. DOI: 10.1093/hmg/6.11.1771. View

15.

Wong A, Yang J, Cavadini P, Gellera C, Lonnerdal B, Taroni F . The Friedreich's ataxia mutation confers cellular sensitivity to oxidant stress which is rescued by chelators of iron and calcium and inhibitors of apoptosis. Hum Mol Genet. 1999; 8(3):425-30. DOI: 10.1093/hmg/8.3.425. View

16.

Knight S, Sepuri N, Pain D, Dancis A . Mt-Hsp70 homolog, Ssc2p, required for maturation of yeast frataxin and mitochondrial iron homeostasis. J Biol Chem. 1998; 273(29):18389-93. DOI: 10.1074/jbc.273.29.18389. View

17.

Kispal G, Csere P, Guiard B, Lill R . The ABC transporter Atm1p is required for mitochondrial iron homeostasis. FEBS Lett. 1998; 418(3):346-50. DOI: 10.1016/s0014-5793(97)01414-2. View

18.

Lamarche J, Cote M, Lemieux B . The cardiomyopathy of Friedreich's ataxia morphological observations in 3 cases. Can J Neurol Sci. 1980; 7(4):389-96. DOI: 10.1017/s0317167100022927. View

19.

Koutnikova H, Campuzano V, Foury F, Dolle P, Cazzalini O, Koenig M . Studies of human, mouse and yeast homologues indicate a mitochondrial function for frataxin. Nat Genet. 1997; 16(4):345-51. DOI: 10.1038/ng0897-345. View

20.

Chasteen N, Antanaitis B, Aisen P . Iron deposition in apoferritin. Evidence for the formation of a mixed valence binuclear iron complex. J Biol Chem. 1985; 260(5):2926-9. View